3. Umbruch 4.4..2005 - Online Pot

160 S.M. Huang and J.M. Walker
30 Nackley AG, Suplita RL 2nd, Hohmann AG (2003) A peripheral cannabinoid mechanism suppresses
spinal fos protein expression and pain behavior in a rat model of inflammation.
Neuroscience 117: 659–670
31 Tsou K, Lowitz KA, Hohmann AG, Martin WJ, Hathaway CB, Bereiter DA, Walker JM (1996)
Suppression of noxious stimulus-evoked expression of FOS protein-like immunoreactivity in rat
spinal cord by a selective cannabinoid agonist. Neuroscience 70: 791–798
32 Martin WJ, Lai NK, Patrick SL, Tsou K, Walker JM (1993) Antinociceptive actions of cannabinoids
following intraventricular administration in rats. Brain Res 629: 300–304
33 Martin WJ, Coffin PO, Attias E, Balinsky M, Tsou K, Walker JM (1999) Anatomical basis for
cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res 822:
237–242
34 Martin WJ, Patrick SL, Coffin PO, Tsou K, Walker JM (1995) An examination of the central sites
of action of cannabinoid-induced antinociception in the rat. Life Sci 56: 2103–2109
35 Martin WJ, Tsou K, Walker JM (1998) Cannabinoid receptor-mediated inhibition of the rat
tail-flick reflex after microinjection into the rostral ventromedial medulla. Neurosci Lett 242:
33–36
36 Lichtman AH, Martin BR (1991) Cannabinoid-induced antinociception is mediated by a spinal
α2-noradrenergic mechanism. Brain Res 559: 309–314
37 Gutierrez T, Nackley AG, Neely MH, Freeman KG, Edwards GL, Hohmann AG (2003) Effects
of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinocicepetion
in models of acute and tonic nociception. Brain Res 987: 176–185
38 Lichtman AH, Martin BR (1991) Spinal and supraspinal components of cannabinoid-induced
antinociception. J Pharmacol Exp Ther 258: 517–523
39 Gilbert PE (1981) A comparison of THC, nantradol, nabilone, and morphine in the chronic spinal
dog. J Clin Pharmacol 21: 311S–319S
40 Smith PB, Martin BR (1992) Spinal mechanisms of ∆ 9 -tetrahydrocannabinol-induced analgesia.
Brain Res 578: 8–12
41 Welch SP, Thomas C, Patrick GS (1995) Modulation of cannabinoid-induced antinociception
after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for
interaction with morphine. J Pharmacol Exp Ther 272: 310–321
42 Yaksh TL (1981) The antinociceptive effects of intrathecally administered levonantradol and
desacetyllevonantradol in the rat. J Clin Pharmacol 21: 334S–340S
43 Harris J, Drew LJ, Chapman V (2000) Spinal anandamide inhibits nociceptive transmission via
cannabinoid receptor activation in vivo. Neuroreport 11: 2817–2819
44 Lim G, Sung B, Ji RR, Mao J (2003) Upregulation of spinal cannabinoid-1-receptors following
nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats. Pain 105:
275–283
45 Richardson JD, Kilo S, Hargreaves KM (1998) Cannabinoids reduce hyperalgesia and inflammation
via interaction with peripheral CB1 receptors. Pain 75: 111–119
46 Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999) Increased mortality,
hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci
USA 96: 5780–5785
47 Malan TP Jr, Ibrahim MM, Deng H, Liu Q, Mata HP, Vanderah T, Porreca F, Makriyannis A
(2001) CB2 cannabinoid receptor-mediated peripheral antinociception. Pain 93: 239–245
48 Clayton N, Marshall FH, Bountra C, O’Shaughnessy CT (2002) CB1 and CB2 cannabinoid
receptors are implicated in inflammatory pain. Pain 96: 253–260
49 Hanusˇ L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA,
Mechoulam R, Fride E (1999) HU-308: A specific agonist for CB(2), a peripheral cannabinoid
receptor. Proc Natl Acad Sci USA 96: 14228–14233
50 Hohmann AG, Farthing JN, Zvonok AM, Makriyannis A (2004) Selective activation of cannabinoid
CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin. J Pharmacol Exp
Ther 308: 446–453
51 Ibrahim MM, Deng H, Zvonok A, Cockayne DA, Kwan J, Mata HP, Vanderah TW, Lai J, Porreca
F, Makriyannis A, Malan TP (2003) Activation of CB2 cannabinoid receptors by AM1241 inhibits
experimental neuropathic pain: Pain inhibition by receptors not present in the CNS. Proc Natl
Acad Sci USA 100: 10529–10533
52 Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Makriyannis A, Malan TP Jr,
(2003) Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid